PDF
(Download)
|
- Red Wine (Vitis vinifera)
- Arteriosclerosis
- Blood Pressure
|
Date:
07-15-2014 | HC# 021413-500
|
Re: Lifestyle Changes and a Daily Glass of Red Wine Do Not Adversely Increase Blood Pressure or Heart Rate in Patients with Arteriosclerosis
Droste DW,
Iliescu C, Vaillant M, et al. A daily glass of red wine and lifestyle changes
do not affect arterial blood pressure and heart rate in patients with carotid
arteriosclerosis after 4 and 20 weeks. Cerebrovasc
Dis Extra. 2013;3(1):121-129.
Lifestyle
changes (LC; healthy diet and physical activity), chocolate (Theobroma cacao), and the Mediterranean
diet, including wine (Vitis vinifera),
tomatoes (Lycopersicon esculentum
syn. Solanum lycopersicum),
and walnuts (Juglans spp.), have all been associated with improved lipid profiles. Although
moderate consumption of red wine has been linked to a reduced risk for cerebro-cardiovascular disease, excessive alcohol consumption has been
associated with high blood pressure (BP) and cerebro-cardiovascular disease. There is limited information
available about the effects of regular intake of alcohol on BP and heart rate
(HR). The goal of this prospective, unblinded, randomized, controlled trial was
to assess the effects of LC and a daily glass of red wine on BP and HR in
patients with arteriosclerosis.
This study took
place in Strassen, Luxembourg. There were 108 patients (67% men) included in
the study that were >30 years, had carotid atherosclerosis (documented by ultrasound),
a mean BP of 122/79 mm Hg,
and a mean HR of 71 bpm.
Exclusion criteria were insufficient blood flow (ocular or cerebral ischemia),
heart rhythm disorders, consistent systolic BP (SBP) >160 mm Hg, or other
complications.
The patients
were randomly divided into groups that received lifestyle counseling (LC group)
or no lifestyle counseling (control group). Within each of these groups, the patients were randomly divided into 2 groups
that were told to avoid alcohol completely or to drink red wine daily (women:
100 ml; men: 200 ml).
In the control group,
the patients were instructed not to change their physical and dietary habits. In
the LC group, the patients met with dietitians for 5 sessions (at baseline, and
after 1, 2, 3, and 4 weeks) to receive advice on healthy eating (i.e., Mediterranean
diet) and physical exercise. The patients were recommended to consume 5
portions of fruit/vegetables per day; a diet low in absolute fat; whole-grain
products; lean meats (e.g., poultry, mostly lean fish); and to reduce
consumption of red meat and unhealthy additives. Patients were also recommended
to regularly consume 1 bar of dark chocolate (25 g, >70% of cacao), 1-2
tomatoes, and 3-5 walnuts, as well as perform at least 30 minutes of moderate
daily physical activity. This group was evaluated at baseline, after 4 weeks,
and after 20 weeks. In both groups, 24-hour BP and HR measurements were carried out every 20 min during daytime
and every 30 min during nighttime.
The primary endpoint
was the mean change in 24-hour SBP assessed at baseline and at 20 weeks. The
secondary endpoints included changes in the mean 24-hour diastolic BP (DBP) and
HR, as well as the mean diurnal and nocturnal effects (SBP, DBP, and HR)
assessed at baseline, 4, and 20 weeks.
The
intent-to-treat (ITT) population evaluated in this study included 108 patients,
whereas the per-protocol (PP) population had 100 patients (8 patients were
excluded in the ITT population because they did not comply with the alcohol
guidelines for their group or were not evaluated at specific time points of the
study). There were no significant differences found among the groups for any of
the baseline parameters evaluated. There were also no serious adverse events
reported in the study. Additionally, patients were found to be mostly
normotensive.
Overall, there
were no significant differences found in the intervention groups (LC group or
red wine group) in comparison to the control groups for absolute change of SBP,
DBP, or HR (for 24-hour, diurnal, and nocturnal measurements) at 4 and 20 weeks.
However, the PP analysis indicated that nocturnal HR was significantly
increased after 4 weeks only in the LC group that consumed wine (P<0.0178).
Based on the
study results, the authors suggest that the beneficial effects (e.g., improved
lipid profiles) of a daily glass of red wine are not counteracted by an
increase in HR or BP; however, the PP analysis indicated that nocturnal HR was
increased as a result of LC and wine consumption. This was partially consistent
with another study that found wine, albeit ingested in higher amounts than in this
study, increased nocturnal HR in normotensive men.1 Therefore, the
effect that wine has on nocturnal HR, and any relevant health implications, should
be further evaluated. Moreover, larger trials that control alcohol consumption
levels and LC may provide more accurate information on BP and HR effects.
—Laura M. Bystrom, PhD
Reference
1Zilkens RR, Burke V,
Hodgson JM, Barden A, Beilin LJ, Puddey IB. Red wine and beer elevate blood
pressure in normotensive men. Hypertension.
2005;45(5):874-879.
|